
57.01 Delayed Data As of Mar 03 | ![]() Today’s Change | 30.79 Today|||52-Week Range 70.82 | -6.59% Year-to-Date |
PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates Feb 25 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Feb 18 / Zacks.com - Paid Partner Content |
Previous close | 57.32 |
Today’s open | 57.42 |
Day’s range | 56.38 - 58.00 |
Volume | 24,875 |
Average volume (3 months) | 502,866 |
Market cap | $4.0B |
Earnings growth (last year) | -55.27% |
Earnings growth (this year) | +12.99% |
Earnings growth (next 5 years) | +2.00% |
Revenue growth (last year) | +24.04% |
P/E ratio | NM |
Price/Sales | 10.58 |
Price/Book | 8.27 |
Today’s change | Today’s % change | |
---|---|---|
INSMInsmed Inc | -0.49 | -1.27% |
---- | ||
GRFSGrifols SA | -0.16 | -0.96% |
HCMHutchison China Medi... | +0.04 | +0.13% |
Next reporting date | May 6, 2021 |
EPS forecast (this quarter) | -$1.59 |
Annual revenue (last year) | $380.8M |
Annual profit (last year) | -$438.2M |
Net profit margin | -115.07% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South Plainfield, New Jersey |